Company · CIK 0001372514 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
KIORA PHARMACEUTICALS INC · KPRX
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 1, 2026 FForm 4 → | Jul 2, 4:47 pm EDT | Melissa ToscaCFO | 911 | $2.66 | $2,423 | 26,064 | — | |
| Jul 1, 2026 FForm 4 → | Jul 2, 4:46 pm EDT | Brian M. StremPresident and CEO, Director | 1,869 | $2.66 | $4,972 | 58,823 | — | |
| Dec 10, 2018 PForm 4 → | Dec 12, 5:23 pm EST | ARMISTICE CAPITAL, LLC +2Director, 10% Owner | — | — | — | 17,262,853 | — | plan? |
| Dec 10, 2018 PForm 4 → | Dec 12, 5:23 pm EST | ARMISTICE CAPITAL, LLC +2Director, 10% Owner | 100,353 | $0.4017 | $40,316 | 17,262,853 | +0.58% | plan? |
| Nov 14, 2018 PForm 4 → | Nov 16, 7:14 pm EST | ARMISTICE CAPITAL, LLC +2Director, 10% Owner | — | — | — | 17,162,500 | — | plan? |
| Nov 14, 2018 PForm 4 → | Nov 16, 7:14 pm EST | ARMISTICE CAPITAL, LLC +2Director, 10% Owner | 360,000 | $0.4483 | $161,395 | 17,162,500 | +2.14% | plan? |
| Jul 10, 2018 AForm 4 → | Jul 12, 5:04 pm EDT | Michael GaranziniChief Commercial Officer | 25,000 | — | — | 196,250 | — | plan? |
| Jul 10, 2018 AForm 4 → | Jul 12, 5:01 pm EDT | Michael P. ManzoVP of Engineering | 175,000 | — | — | 194,546 | — | plan? |
| Jul 10, 2018 AForm 4 → | Jul 12, 5:00 pm EDT | Stephen FromPresident and CEO, Director | 750,000 | — | — | 1,159,820 | — | plan? |
| Jul 10, 2018 AForm 4 → | Jul 12, 4:58 pm EDT | Bernard Malfroy-CamineDirector | 50,000 | — | — | 61,525 | — | plan? |
| Jul 10, 2018 AForm 4 → | Jul 12, 4:57 pm EDT | Morton GoldbergDirector | 50,000 | — | — | 59,441 | — | plan? |
| Jul 10, 2018 AForm 4 → | Jul 12, 4:55 pm EDT | Paul G ChaneyDirector | 50,000 | — | — | 91,229 | — | plan? |
| Jul 10, 2018 AForm 4 → | Jul 12, 4:54 pm EDT | Brenda MannVP of Research & Development | 175,000 | — | — | 193,473 | — | plan? |
| Jul 10, 2018 AForm 4 → | Jul 12, 4:52 pm EDT | Praveen TyleDirector | 50,000 | — | — | 61,893 | — | plan? |
| Jul 10, 2018 AForm 4 → | Jul 12, 4:51 pm EDT | Sarah RomanoChief Financial Officer | 175,000 | — | — | 281,863 | — | plan? |
| Jul 10, 2018 AForm 4 → | Jul 12, 4:49 pm EDT | Barbara WirostkoChief Medical Officer | 175,000 | — | — | 424,997 | — | plan? |
| Jun 7, 2018 AForm 4/A → | Jun 13, 4:32 pm EDT | Barbara WirostkoChief Medical Officer | 18,815 | $0.5274 | $9,924 | 59,915 | — | plan? |
| Jun 7, 2018 AForm 4 → | Jun 11, 8:37 pm EDT | Barbara WirostkoChief Medical Officer | 9,215 | $0.5352 | $4,932 | 249,612 | — | plan? amended |
| May 25, 2018 PForm 4 → | May 30, 6:05 pm EDT | ARMISTICE CAPITAL, LLC +2Director, 10% Owner | — | — | — | 16,802,500 | — | plan? |
| May 25, 2018 PForm 4 → | May 30, 6:05 pm EDT | ARMISTICE CAPITAL, LLC +2Director, 10% Owner | 58,275 | $0.5737 | $33,433 | 16,802,500 | +0.35% | plan? |
| May 18, 2018 PForm 4 → | May 22, 5:40 pm EDT | ARMISTICE CAPITAL, LLC +2Director, 10% Owner | — | — | — | 16,744,225 | — | plan? |
| May 18, 2018 PForm 4 → | May 22, 5:40 pm EDT | ARMISTICE CAPITAL, LLC +2Director, 10% Owner | 1,725 | $0.556 | $959 | 16,744,225 | +0.01% | plan? |
| May 14, 2018 PForm 4 → | May 16, 5:54 pm EDT | ARMISTICE CAPITAL, LLC +2Director, 10% Owner | — | — | — | 16,742,500 | — | plan? |
| May 14, 2018 PForm 4 → | May 16, 5:54 pm EDT | ARMISTICE CAPITAL, LLC +2Director, 10% Owner | 15,758 | $0.5342 | $8,417 | 16,742,500 | +0.09% | plan? |
| May 9, 2018 PForm 4 → | May 11, 6:02 pm EDT | ARMISTICE CAPITAL, LLC +210% Owner | — | — | — | 16,726,742 | — | plan? |
| May 9, 2018 PForm 4 → | May 11, 6:02 pm EDT | ARMISTICE CAPITAL, LLC +210% Owner | 177,012 | $0.514 | $90,992 | 16,726,742 | +1.07% | plan? |
| May 4, 2018 PForm 4 → | May 8, 6:22 pm EDT | ARMISTICE CAPITAL, LLC +210% Owner | — | — | — | 16,549,730 | — | plan? |
| May 4, 2018 PForm 4 → | May 8, 6:22 pm EDT | ARMISTICE CAPITAL, LLC +210% Owner | 137,230 | $0.4625 | $63,472 | 16,549,730 | +0.84% | plan? |
| Apr 25, 2018 PForm 4 → | Apr 27, 5:54 pm EDT | ARMISTICE CAPITAL, LLC +210% Owner | — | — | — | 16,412,500 | — | plan? |
| Apr 25, 2018 PForm 4 → | Apr 27, 5:54 pm EDT | ARMISTICE CAPITAL, LLC +210% Owner | 165,522 | $0.5393 | $89,266 | 16,412,500 | +1.02% | plan? |
| Apr 18, 2018 PForm 4 → | Apr 20, 5:38 pm EDT | ARMISTICE CAPITAL, LLC +210% Owner | — | — | — | 16,246,978 | — | plan? |
| Apr 18, 2018 PForm 4 → | Apr 20, 5:38 pm EDT | ARMISTICE CAPITAL, LLC +210% Owner | 2,534,478 | $0.4858 | $1,231,159 | 16,246,978 | +18.5% | plan? |
| Apr 17, 2018 PForm 4 → | Apr 18, 5:24 pm EDT | Michael GaranziniChief Commercial Officer | 156,250 | — | — | 171,250 | — | plan? |
| Apr 17, 2018 PForm 4 → | Apr 18, 5:23 pm EDT | Stephen FromPresident and CEO, Director | 125,000 | — | — | 409,820 | — | plan? |
| Apr 17, 2018 PForm 4 → | Apr 18, 5:22 pm EDT | Sarah RomanoChief Financial Officer | 62,500 | — | — | 106,863 | — | plan? |
| Apr 13, 2018 PForm 4 → | Apr 17, 9:59 pm EDT | ARMISTICE CAPITAL, LLC +210% Owner | — | — | — | 13,712,500 | — | plan? amended |
| Apr 13, 2018 PForm 4 → | Apr 17, 9:59 pm EDT | ARMISTICE CAPITAL, LLC +210% Owner | 10,479,970 | $0.3569 | $3,740,050 | 13,712,500 | +324% | plan? amended |
| Dec 29, 2017 JForm 4 → | Jan 3, 2018, 4:10 pm EST | Sarah RomanoChief Financial Officer | 11,863 | $1.01 | $11,982 | 44,363 | — | plan? |
| Dec 29, 2017 JForm 4 → | Jan 3, 2018, 4:07 pm EST | Barbara WirostkoChief Medical Officer | 12,355 | $1.01 | $12,479 | 240,397 | — | plan? |
| Dec 29, 2017 JForm 4 → | Jan 3, 2018, 4:07 pm EST | Brenda MannVP of Research & Development | 6,722 | $1.01 | $6,789 | 18,473 | — | plan? |
| Dec 29, 2017 JForm 4 → | Jan 3, 2018, 4:05 pm EST | Stephen FromPresident and CEO, Director | 12,355 | $1.01 | $12,479 | 284,820 | — | plan? |
| Nov 17, 2017 AForm 4 → | Nov 22, 4:15 pm EST | Michael GaranziniChief Commercial Officer | 15,000 | $1.07 | $16,050 | 15,000 | — | plan? late |
| Sep 14, 2017 AForm 4 → | Sep 15, 4:29 pm EDT | Barbara WirostkoChief Medical Officer | 19,200 | $1.22 | $23,334 | 228,042 | — | plan? |
| Aug 15, 2017 PForm 4 → | Aug 17, 4:05 pm EDT | Sarah RomanoInterim CFO | 10,000 | $1.00 | $10,000 | 32,500 | +44.4% | plan? |
| Aug 10, 2017 PForm 4 → | Aug 10, 5:57 pm EDT | Stephen FromPresident and CEO, Director | 12,500 | $1.03 | $12,875 | 272,465 | +4.81% | plan? |
| Jun 14, 2017 PForm 4 → | Jun 14, 4:51 pm EDT | Sarah RomanoInterim CFO | 20,000 | — | — | 22,500 | — | plan? |
| Jun 14, 2017 PForm 4 → | Jun 14, 4:50 pm EDT | Stephen FromPresident and CEO, Director | 60,000 | — | — | 259,965 | — | plan? |
| Jun 2, 2017 MForm 4 → | Jun 5, 7:41 pm EDT | Paul G ChaneyDirector | 17,570 | $0.65 | $11,421 | 41,229 | — | plan? |
| May 15, 2017 MForm 4 → | May 15, 4:51 pm EDT | Michael P. ManzoVice President of Engineering | 7,285 | $0.65 | $4,735 | 19,546 | — | plan? |
| Mar 13, 2017 SForm 4 → | Mar 21, 4:47 pm EDT | Ventech Capital II10% Owner | 4,419 | $2.80 | $12,385 | 1,431,814 | −0.31% | plan? late |
| Mar 7, 2017 AForm 4 → | Mar 7, 5:52 pm EST | Barbara WirostkoChief Medical Officer | 8,700 | $2.83 | $24,621 | 217,842 | — | plan? |
| Mar 6, 2017 SForm 4 → | Mar 6, 4:05 pm EST | Morton GoldbergDirector | 8,919 | $3.00 | $26,757 | 9,441 | −48.6% | plan? |
| Feb 28, 2017 AForm 4 → | Mar 1, 5:25 pm EST | Barbara WirostkoChief Medical Officer | 95,900 | $2.59 | $248,798 | 41,700 | — | plan? |
| Feb 27, 2017 MForm 4 → | Mar 1, 5:24 pm EST | Morton GoldbergDirector | 1,083 | $1.70 | $1,841 | 18,360 | — | plan? |
| Feb 6, 2017 AForm 4 → | Feb 8, 4:27 pm EST | Sarah RomanoInterim CFO | 2,500 | — | — | 2,500 | — | plan? |
| Feb 6, 2017 AForm 4 → | Feb 7, 4:16 pm EST | Brenda MannVP of Research & Development | 2,500 | — | — | 11,751 | — | plan? |
| Feb 6, 2017 AForm 4 → | Feb 7, 4:16 pm EST | Barbara WirostkoChief Medical Officer | 15,000 | — | — | 154,942 | — | plan? |
| Feb 6, 2017 AForm 4 → | Feb 7, 4:15 pm EST | Stephen FromPresident and CEO, Director | 60,000 | — | — | 199,965 | — | plan? |
| Sep 15, 2016 PForm 4 → | Sep 16, 4:15 pm EDT | Stephen FromPresident and CEO, Director | 15,000 | $1.49 | $22,338 | 139,965 | +12.0% | plan? |
| Jun 30, 2016 MForm 4 → | Jul 5, 4:11 pm EDT | Stephen FromPresident and CEO, Director | 52,990 | $0.6478 | $34,327 | 124,965 | — | plan? |
| Jun 15, 2016 SForm 4 → | Jun 15, 5:10 pm EDT | Morton GoldbergDirector | 15,000 | $3.16 | $47,361 | 17,277 | −46.5% | plan? |
| Jun 9, 2016 SForm 4 → | Jun 10, 4:21 pm EDT | Ventech Capital II10% Owner | 28,600 | $3.04 | $86,856 | 1,593,540 | −1.76% | plan? |
| Jun 6, 2016 SForm 4 → | Jun 9, 4:29 pm EDT | Ventech Capital II10% Owner | 29,400 | $3.25 | $95,424 | 1,622,140 | −1.78% | plan? late |
| Jun 3, 2016 SForm 4 → | Jun 7, 5:42 pm EDT | Morton GoldbergDirector | 10,939 | $3.31 | $36,203 | 32,277 | −25.3% | plan? |
| Jun 3, 2016 MForm 4 → | Jun 7, 5:42 pm EDT | Morton GoldbergDirector | 33,775 | $0.6478 | $21,879 | 43,216 | — | plan? |
| Mar 7, 2016 JForm 4 → | Mar 9, 6:22 pm EST | Barbara WirostkoChief Medical Officer | 139,942 | — | — | 139,942 | — | plan? |
| Mar 7, 2016 JForm 4 → | Mar 9, 6:21 pm EST | Brenda MannVP of Research & Development | 9,251 | — | — | 9,251 | — | plan? |
| Aug 28, 2015 AForm 4 → | Sep 1, 4:10 pm EDT | Paul G ChaneyDirector | 7,408 | — | — | 23,659 | — | plan? |
| Aug 28, 2015 AForm 4 → | Sep 1, 4:09 pm EDT | Thomas BallandDirector | 5,037 | — | — | 10,422 | — | plan? |
| Aug 28, 2015 AForm 4 → | Sep 1, 4:09 pm EDT | Mounia ChaouiDirector | 5,037 | — | — | 10,422 | — | plan? |
| Aug 28, 2015 AForm 4 → | Sep 1, 4:08 pm EDT | Thomas HancockDirector | 6,519 | — | — | 13,487 | — | plan? |
| Aug 28, 2015 AForm 4 → | Sep 1, 4:07 pm EDT | Bernard Malfroy-CamineDirector | 5,570 | — | — | 11,525 | — | plan? |
| Aug 28, 2015 AForm 4 → | Sep 1, 4:07 pm EDT | Praveen TyleDirector | 5,748 | — | — | 11,893 | — | plan? |
| Aug 28, 2015 AForm 4 → | Sep 1, 4:06 pm EDT | Morton GoldbergDirector | 4,563 | — | — | 9,441 | — | plan? |
| Aug 28, 2015 AForm 4 → | Sep 1, 4:06 pm EDT | Michael P. ManzoVice President of Engineering | 5,926 | — | — | 12,261 | — | plan? |
| Aug 28, 2015 AForm 4 → | Sep 1, 4:05 pm EDT | Stephen FromPresident and CEO, Director | 14,807 | — | — | 71,975 | — | plan? |
| May 1, 2015 AForm 4 → | May 5, 5:17 pm EDT | Paul G ChaneyDirector | 15,326 | — | — | 23,659 | — | plan? |
| May 1, 2015 AForm 4 → | May 5, 5:15 pm EDT | Morton GoldbergDirector | 9,441 | — | — | 9,441 | — | plan? |
| May 1, 2015 AForm 4 → | May 5, 5:14 pm EDT | Michael P. ManzoVice President of Engineering | 12,261 | — | — | 12,261 | — | plan? |
| May 1, 2015 AForm 4 → | May 5, 5:12 pm EDT | Praveen TyleDirector | 11,893 | — | — | 11,893 | — | plan? |
| May 1, 2015 AForm 4 → | May 5, 5:11 pm EDT | Bernard Malfroy-CamineDirector | 11,525 | — | — | 11,525 | — | plan? |
| May 1, 2015 AForm 4 → | May 5, 5:09 pm EDT | Thomas HancockDirector | 13,487 | — | — | 13,487 | — | plan? |
| May 1, 2015 AForm 4 → | May 5, 5:07 pm EDT | Mounia ChaouiDirector | 10,422 | — | — | 10,422 | — | plan? |
| May 1, 2015 AForm 4 → | May 5, 5:05 pm EDT | Thomas BallandDirector | 10,422 | — | — | 10,422 | — | plan? |
| May 1, 2015 AForm 4 → | May 5, 5:02 pm EDT | Stephen FromPresident and CEO, Director | 30,635 | — | — | 71,975 | — | plan? |
| Feb 19, 2015 PForm 4 → | Feb 23, 5:47 pm EST | Paul G ChaneyDirector | 8,333 | $6.00 | $49,998 | 8,333 | — | plan? |
| Feb 19, 2015 PForm 4 → | Feb 23, 5:41 pm EST | Ventech Capital II10% Owner | 102,777 | $6.00 | $616,662 | 1,494,233 | +7.39% | plan? |
| Feb 19, 2015 CForm 4 → | Feb 23, 5:41 pm EST | Ventech Capital II10% Owner | 1,391,456 | $4.20 | $1,013,334 | 1,391,456 | — | plan? |
| Feb 19, 2015 CForm 4 → | Feb 23, 5:39 pm EST | NATIXIS PRIVATE EQUITY10% Owner | 674,205 | $4.20 | $410,092 | 674,205 | — | plan? |
| Feb 19, 2015 PForm 4 → | Feb 23, 5:33 pm EST | (innoven Partenaires S.A.) Ipsa10% Owner | 366,667 | $6.00 | $2,200,002 | 1,460,479 | +33.5% | plan? |
| Feb 19, 2015 CForm 4 → | Feb 23, 5:33 pm EST | (innoven Partenaires S.A.) Ipsa10% Owner | 1,093,812 | $4.20 | $580,415 | 1,093,812 | — | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 19, 2015 CPForm 4 → | Feb 23, 5:41 pm EST | Ventech Capital II10% Owner | 169,849 | — | — | 0 | — | |
| Feb 19, 2015 CPForm 4 → | Feb 23, 5:39 pm EST | NATIXIS PRIVATE EQUITY10% Owner | 576,564 | — | — | 0 | — | |
| Feb 19, 2015 AForm 4 → | Feb 23, 5:37 pm EST | Stephen FromPresident and CEO, Director | 3,642 | — | — | 261,271 | — | |
| Feb 19, 2015 AForm 4 → | Feb 23, 5:37 pm EST | Praveen TyleDirector | 2,276 | — | — | 36,051 | — | |
| Feb 19, 2015 AForm 4 → | Feb 23, 5:36 pm EST | Thomas HancockDirector | 2,276 | — | — | 2,276 | — | |
| Feb 19, 2015 AForm 4 → | Feb 23, 5:35 pm EST | Mounia ChaouiDirector | 2,276 | — | — | 2,276 | — | |
| Feb 19, 2015 AForm 4 → | Feb 23, 5:34 pm EST | Michael P. ManzoVice President of Engineering | 3,187 | — | — | 52,973 | — | |
| Feb 19, 2015 CPForm 4 → | Feb 23, 5:33 pm EST | (innoven Partenaires S.A.) Ipsa10% Owner | 955,618 | — | — | 0 | — | |
| Feb 19, 2015 AForm 4 → | Feb 23, 5:33 pm EST | Morton GoldbergDirector | 2,276 | — | — | 36,051 | — | |
| Feb 19, 2015 AForm 4 → | Feb 23, 5:32 pm EST | Bernard Malfroy-CamineDirector | 2,276 | — | — | 10,631 | — |